At the protein level, the HPA database confirmed that the expression of COL5A1 in breast cancer was higher than that in normal tissues, which was consistent with the results of immunohistochemistry; moreover, the COL5A1 mutation was negatively correlated with the prognosis of breast cancer patients (Wu et al., 2019). The gene discussed is COL5A1; the disease is breast cancer.